首页 › 基金 › SILVERARC CAPITAL MANAGEMENT, LLC › DARE
SILVERARC CAPITAL MANAGEMENT, LLC 对 DARE 的持仓历史
YARROW BIOSCIENCE INC · 医疗保健
SILVERARC CAPITAL MANAGEMENT, LLC 在 Q3 2026 的 13F 申报中披露持有 DARE(YARROW BIOSCIENCE INC)301,919 股,市值约 US$6.8M,约占其申报组合的 0.87%,在其申报持仓中市值排名第 31 位。 SILVERARC CAPITAL MANAGEMENT, LLC 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
SILVERARC CAPITAL MANAGEMENT, LLC 对 DARE 的持仓演变
SILVERARC CAPITAL MANAGEMENT, LLC 于 Q3 2026 首次披露 DARE 持仓:301,919 股(约 US$6.8M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 301.92K | $6.80M | 新进 |
关于 DARE 与 13F 数据
DARE(YARROW BIOSCIENCE INC)属于医疗保健行业。我们追踪的基金中还有 26 只申报持有 DARE,申报仓位最大的包括:Monashee Investment Management LLC (US$901K)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 SILVERARC CAPITAL MANAGEMENT, LLC
常见问题
How long has SILVERARC CAPITAL MANAGEMENT, LLC held DARE?
SILVERARC CAPITAL MANAGEMENT, LLC has disclosed DARE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in DARE?
As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 301.92K shares of DARE (YARROW BIOSCIENCE INC), valued at $6.80M, representing 0.87% of its reported portfolio and ranking #31.
Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling DARE?
In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC newly opened its position in DARE.
Which other funds hold DARE?
Other major institutional holders of DARE include Monashee Investment Management LLC, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.